Carcinoma ex-pleomorphic adenoma of the salivary glands has a high risk of progression when the tumor invades more than 2.5 mm beyond the capsule of the residual pleomorphic adenoma.

Histological, immunohistological and molecular characteristics of intraductal precursor of carcinoma ex pleomorphic adenoma support a multistep carcinogenic process. Virchows Arch (2017) 0.75

Tumors of the major salivary glands. Cancer (1953) 3.77

Malignant mixed tumors of the salivary glands: a review. Pathol Annu (1993) 2.19

Salivary duct carcinoma. Clinicopathologic and immunohistochemical review of 26 cases. Cancer (1996) 1.95

Carcinoma ex pleomorphic adenoma: a clinicopathologic review. Head Neck (2001) 1.85

Malignant mixed tumors arising in salivary glands. I. Carcinomas arising in benign mixed tumors: a clinicopathologic study. Cancer (1977) 1.66

An update on grading of salivary gland carcinomas. Head Neck Pathol (2009) 1.61

Salivary duct carcinoma: targeting the phosphatidylinositol 3-kinase pathway by blocking mammalian target of rapamycin with temsirolimus. J Clin Oncol (2011) 1.58

Carcinomas ex pleomorphic adenoma and malignant mixed tumors. Histomorphologic indexes. Arch Otolaryngol (1984) 1.53

Carcinoma ex pleomorphic adenoma: a comprehensive review of clinical, pathological and molecular data. Head Neck Pathol (2011) 1.52

Carcinoma ex pleomorphic adenoma (CXPA): immunoprofile of the cells involved in carcinomatous progression. Histopathology (2005) 1.31

Noninvasive and minimally invasive carcinoma ex mixed tumor: a clinicopathologic and ploidy study of 12 patients with major salivary tumors of low (or no?) malignant potential. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (1996) 1.29

Successful treatment of pulmonary metastatic salivary ductal carcinoma with trastuzumab-based therapy. Head Neck (2008) 1.25

Biological therapy of salivary duct carcinoma. J Laryngol Otol (2008) 1.22

Prognostic factors of recurrence in salivary carcinoma ex pleomorphic adenoma, with emphasis on the carcinoma histologic subtype: a clinicopathologic study of 43 cases. Hum Pathol (2010) 1.14

Non-invasive (intracapsular) carcinoma ex pleomorphic adenoma: recognition of focal carcinoma by HER-2/neu and MIB1 immunohistochemistry. Histopathology (2005) 1.07

Detection of novel actionable genetic changes in salivary duct carcinoma helps direct patient treatment. Clin Cancer Res (2012) 1.06

Targeted therapy with trastuzumab for advanced salivary ductal carcinoma: case report and literature review. Med Oncol (2011) 1.06

Carcinoma ex pleomorphic adenoma, with particular emphasis on early lesions. Head Neck Pathol (2013) 1.01

PIK3CA mutations and PTEN loss in salivary duct carcinomas. Am J Surg Pathol (2013) 0.97

Malignant mixed tumors of salivary gland origin. Cancer (1969) 0.95

Prognostic factors affecting the clinical outcome of carcinoma ex pleomorphic adenoma in the major salivary gland. World J Surg Oncol (2013) 0.92

Carcinoma ex pleomorphic adenoma with special reference to the prognostic significance of histological progression: a clinicopathological investigation of 41 cases. Histopathology (2011) 0.92

Carcinoma ex pleomorphic adenoma in a Brazilian population: clinico-pathological analysis of 38 cases. Int J Oral Maxillofac Surg (2013) 0.87

Salivary duct carcinoma and the concept of early carcinoma ex pleomorphic adenoma. Histopathology (2014) 0.83

Predictors of survival in carcinoma ex pleomorphic adenoma. Head Neck (2014) 0.78